Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS).

Acta cardiologica - 1 Jun 2006

Maitland-van der Zee Anke-Hilse, Jukema J Wouter, Zwinderman Aeilko H, Hallman D Michael, De Boer Anthonius, Kastelein John J P, De Knijff Peter

Abstract excerpt

OBJECTIVE: [corrected] The influence ofApoE polymorphism on the efficacy of statins in lowering plasma lipids and lipoproteins and improving angiographic parameters was assessed. METHODS: ApoE genotypes were studied in a group (n = 815) of well-characterised male coronary artery disease (CAD) patients who participated in the lipid-lowering regression study 'Regression Growth Evaluation Statin Study (REGRESS)'....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticholesteremic Agents
Share to Apolipoprotein E2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoprotein E3

Share to Cholesterol, HDL

Share to Cholesterol, LDL

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Pravastatin

Share to Statistics as Topic

Source

Identifiers

PMID: 16869455
DOI: 10.2143/AC.61.3.2014836

Genes

APOE
CAD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS).PMID 16869455Read ↗

Effect of apolipoprotein E polymorphism on statin-induced decreases in plasma lipids and cardiovascular events.Semantic proximity Read ↗

Apolipoprotein E polymorphisms influence effect of pravastatin on survival after myocardial infarction in a Mediterranean population: the GISSI-Prevenzione study.Semantic proximity Read ↗

APOE genotype and the effect of statins on lipid outcomes: A meta-analysis.Semantic proximity Read ↗

APOE genotype and the effect of statins: a systematic review and meta-analysisSemantic proximity Read ↗

Improvement of myocardial blood flow by lipid-lowering therapy with pravastatin is modulated by apolipoprotein E genotype.Semantic proximity Read ↗

Association of APOE polymorphisms with lipid-lowering efficacy of statins in atherosclerotic cardiovascular diseases.Semantic proximity Read ↗

Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy.Semantic proximity Read ↗

Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner.Semantic proximity Read ↗

APOE gene polymorphisms and response to statin therapy.Semantic proximity Read ↗

Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy.Semantic proximity Read ↗

Effect of apoE genotype on the hypolipidaemic response to pravastatin in an outpatient setting.Semantic proximity Read ↗

In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.